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Plasma levels of C ‑reactive protein (CRP) were 
measured by the cardiac C ‑reactive protein test 
(Roche, Mannheim, Germany). The estimation 
of RVSP with transthoracic echocardiography 
using the continuous wave doppler method was 
based on the measurement of the peak tricus‑
pid valve regurgitation jet velocity, according 
to the simplified Bernoulli equation and tak‑
ing into account right atrial pressure. All treat‑
ments were performed through median sternot‑
omy under general anesthesia and normother‑
mic conditions. The primary endpoint at the in‑
hospital follow ‑up was the postoperative diag‑
nosis of pneumonia. Pneumonia was diagnosed 
based on new typical clinical symptoms (such 
as cough, fever, chills, malaise, sweating, chest 
pain, dyspnea), auscultatory changes located 
over a certain chest area, changes in radiologi‑
cal image of the thorax such as increased com‑
paction in the lung fields, and increase in inflam‑
mation parameters in laboratory tests such as 
leukocytosis and CRP concentration. Patients 
were followed for 30 days. In the case of pro‑
longed hospitalization, the follow ‑up lasted un‑
til the end of stay. The study protocol was ap‑
proved by the institutional ethics committee 
(approval no. 1705).
Statistical analysis All analyses were per‑
formed using the SAS software, version 9.2 
(SAS Institute Inc., Cary, North Carolina, Unit‑
ed States). Data are presented as mean (SD) 
and frequency (percentage). Logistic regres‑
sion was used to assess relationships between 
variables. Significant determinants (P <0.05) 
identified on the basis of univariate analysis 
Introduction Hospital ‑acquired pneumo‑
nia is one of the complications in patients un‑
dergoing heart valve surgery.1 The definition 
of hospital ‑acquired pneumonia includes in‑
flammation that develops 48 hours after admis‑
sion to the hospital. Risk factors for hospital‑
‑acquired pneumonia include the postopera‑
tive use of a nasogastric tube, prolonged intu‑
bation, transfusion of packed red blood cells, 
older age, chronic obstructive pulmonary dis‑
ease, steroid use, lower hemoglobin levels, or 
heart transplants.2‑5 Knowledge of predictors 
of postoperative pneumonia enables the imple‑
mentation of an appropriate perioperative strat‑
egy, which in turn allows to improve treatment 
outcomes in patients with valvular heart dis‑
ease.6 Therefore, the aim of the present study 
was to assess the usefulness of preoperative 
measurement of right ventricular systolic pres‑
sure (RVSP) by means of transthoracic echocar‑
diography for hospital ‑acquired pneumonia in 
the postoperative period in patients undergo‑
ing heart valve surgery.
Methods This was a  prospective study 
in a group of consecutive patients with hemo‑
dynamically significant valvular heart disease 
(aortic valve stenosis, aortic regurgitation, mi‑
tral stenosis, and mitral regurgitation) under‑
going valve surgery at the Institute of Cardiol‑
ogy in Warsaw, Poland. The exclusion criteria 
were: age under 18 years, lack of consent to par‑
ticipate in the study, massive tricuspid regurgi‑
tation, active malignant diseases, autoimmune 
diseases, active endocarditis, and significant 
atherosclerotic lesions in the coronary arteries. 
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time ‑consuming, invasive, and limited‑access 
procedure. Therefore, a noninvasive diagnostic 
tool evaluating RVSP, such as echocardiography, 
despite limitations, is very helpful in assessing 
the likelihood of pulmonary hypertension.8,9
Pneumonia is one of the complications that 
may occur in the early postoperative period 
in patients undergoing heart valve surgery. 
Moreover, it is burdened by a risk of prolonged 
hospitalization, respiratory failure, reintuba‑
tion, and death.10 The natural defense mech‑
anisms of the respiratory system ensure that 
the lower respiratory tracts are physiological‑
ly sterile. Microbes most often enter the lower 
respiratory tract with aspiration. Bacteria are 
usually killed by the immune cells in the lungs. 
However, under favorable conditions, the bac‑
teria are able to survive, which stimulates 
the body to defend.
A significant valve defect in the left part 
of the heart is one of the causes of elevated 
pulmonary artery pressure,11,12 and persistent‑
ly high pressure in pulmonary circulation ves‑
sels are associated with various pathophysio‑
logical mechanisms. Persistent elevated resis‑
tance in pulmonary vessels may lead to pulmo‑
nary vascular endothelial dysfunction, which 
in turn leads to a reduced production of anti‑
proliferative substances, for example, nitric 
oxide and prostacyclin. Vascular endothelial 
dysfunction is also accompanied by overex‑
pression of vasoconstrictive and proliferative 
compounds, for example, thromboxane A2 and 
endothelin 1. Many of these abnormalities in‑
crease vascular tone and promote vascular re‑
modeling involving the proliferation of endo‑
thelial cells, smooth muscle cells, and fibro‑
blasts. In addition, there is increased produc‑
tion of the collagen, elastin, fibronectin, and 
tenascin range in the extracellular matrix, as 
well as increased accumulation of inflammato‑
ry cells.13,14 It seems, therefore, that the patho‑
physiological processes occurring in the lungs 
with, among others, a chronic enhanced inflam‑
matory state (one of the exponents of the in‑
flammation is CRP) in patients with elevat‑
ed pressure in the pulmonary circulation ves‑
sels (which confirms the correlation between 
RVSP and CRP demonstrated in the present 
study) make the patients more susceptible to 
infections that may occur in the early postop‑
erative period.15
The results of the present study indicate that 
patients with higher preoperative RVSP may 
be prone to postoperative pneumonia and worse 
long‑term outcomes. Knowledge of the predic‑
tors of postoperative pneumonia is extreme‑
ly important because it allows the implemen‑
tation of an appropriate perioperative strategy, 
including maintaining rigorous aseptic princi‑
ples, which in turn can improve treatment out‑
comes in patients with valvular heart disease.
were subsequently introduced into multivar‑
iate models. The Spearman rank correlation 
analysis was used to search for associations 
between the preoperative value of CRP level 
and RVSP. The cut ‑off point for the RVSP val‑
ue, which fulfilled the criterion of maximum 
sensitivity and specificity for postoperative he‑
modynamic instability, was determined based 
on the Youden index.
Results and discussion The present study 
included 631 patients undergoing heart valve 
surgery. The mean (SD) age in the study pop‑
ulation was 62 (12) years. Chronic obstructive 
pulmonary disease was present in 49 patients 
(7%). The mean (SD) preoperative RVSP level 
was 44 (17) mm Hg. Postoperative pneumonia 
occurred in 24 patients. The mean (SD) time to 
the diagnosis of pneumonia was 3.5 (2) days af‑
ter surgery. Each patient with pneumonia re‑
ceived empiric antibiotic therapy. Due to the lack 
of improvement in clinical status, antibiotic 
therapy was switched in 5 patients, including 3 
patients with positive microbiological test result. 
Significant predictors of postoperative hospital‑
‑acquired pneumonia at univariate analysis are 
presented in TAble 1. At multivariate analysis only 
RVSP (odds ratio, 1.043; 95% confidence interval, 
1.018–1.067; P = 0.004) remained an indepen‑
dent predictor of the primary endpoint. The op‑
timal cut ‑off point for primary endpoint was 
calculated at 46 mm Hg. The area under receiv‑
er operator characteristic curve for postopera‑
tive pneumonia for RVSP was 0.781 (95% con‑
fidence interval, 747–0.813). A positive corre‑
lation was found between the level of CRP and 
RVSP (r = 0.31; P = 0.001). Out of the patients 
who had postoperative hospital ‑acquired pneu‑
monia, 6 patients died due to increased cardio‑
respiratory failure.
In the present study conducted on a group 
of 631 patients undergoing heart valve surgery, 
RVSP was an independent predictor of postop‑
erative pneumonia. Pulmonary hypertension 
often complicates the course of cardiovascu‑
lar disease. The gold standard for the measure‑
ment of pulmonary artery pressure is right heart 
catheterization.7 It is, however, an expensive, 
Table 1 Univariate analysis of predictive factors for the occurrence 
of the composite endpoint
Variable OR 95% Cl P value
RVSP, mm Hg 1.030 1.013–1.048 <0.001
CRP, mg/dl 1.396 1.058–1.843 0.01
Hemoglobin, g/dl 0.690 0.551–0.862 0.001
NYHA classes 2.024 1.040–3.936 0.03
Abbreviations: CRP, C ‑reactive protein; NYHA, New York Heart Association; OR, odds ratio; RVSP, 
right ventricular systolic pressure
S H O R T  C O M M U N I C A T I O N  RVSP as a predictor of postoperative pneumonia 971
Article informAtion
conflict of interest None declared.
open Access This is an Open Access article distributed under the terms 
of  the  Creative  Commons  Attribution ‑NonCommercial ‑NoDerivatives  4.0  In‑
ternational  license  (CC bY ‑NC ‑ND  4.0),  allowing  third  parties  to  download  ar‑
ticles and share them with others, provided the original work is properly cited, 
not changed in any way, distributed under the same license, and used for non‑
commercial purposes only. For commercial use, please contact the journal office 
at kardiologiapolska@ptkardio.pl.
How to cite Duchnowski P, Hryniewiecki T, Kuśmierczyk M, Szymański P. 
Right ventricular systolic pressure as a predictive factor for postoperative pneu‑
monia  in  patients with  valvular  heart  disease.  Kardiol  Pol.  2019;  77:  969‑971. 
doi:10.33963/KP.14940
references
1  Thompson MP, Cabrera L, Strobel RJ, et al. Association between postoperative 
pneumonia and 90‑day episode payments and outcomes among Medicare beneficia‑
ries undergoing cardiac surgery. Circ Cardiovasc Qual Outcomes. 2018; 11: e004818.
2  Ailawadi G, Chang HL, O’Gara PT, et al. Pneumonia after cardiac surgery: ex‑
perience of  the National  Institutes of Health/Canadian  Institutes of Health Re‑
search Cardiothoracic Surgical  Trials Network.  J  Thorac Cardiovasc Surg. 2017; 
153: 1384‑1391.
3  Liu Y, An Z, Chen J, et al. Risk factors for noninvasive ventilation failure in pa‑
tients with post ‑extubation acute respiratory failure after cardiac surgery. J Thorac 
Dis. 2018; 10: 3319‑3328.
4  Sheng W, Xing QS, Hou WM, et al.  Independent  risk  factors  for ventilator‑
‑associated pneumonia after cardiac surgery. J Invest Surg. 2014; 27: 256‑261.
5  Allou N, Bronchard R, Guglielminotti J, et al. Risk factors for postoperative 
pneumonia after cardiac surgery and development of a preoperative risk score. 
Crit Care Med. 2014; 42: 1150‑1156.
6  Duchnowski  P,  Hryniewiecki  T,  Kuśmierczyk M,  et  al.  Red  cell  distribution 
width as a predictor of multiple organ dysfunction syndrome in patients undergo‑
ing heart valve surgery. biol Open. 2018; 7: bio036251.
7  Galiè N, Humbert M, Vachiery Jl, et al. 2015 eSC/eRS Guidelines for the diag‑
nosis and treatment of pulmonary hypertension: the Joint Task Force for the Diag‑




8  Nathan SD, Shlobin OA, Barnett SD, et al. Right ventricular systolic pressure 
by echocardiography as a predictor of pulmonary hypertension in idiopathic pul‑
monary fibrosis. Respir Med. 2008; 102: 1305‑1310.
9  Ahmed SN, Syed FM, Porembka DT. Echocardiographic evaluation of hemody‑
namic parameters. Crit Care Med. 2007; 35 (suppl 8): S323‑S329.
10  Safdar N,  Crnich  CJ, Maki  DG.  The  pathogenesis  of  ventilator ‑associated 
pneumonia: its relevance to developing effective strategies for prevention. Respir 
Care. 2005; 50: 725‑739.
11  Duchnowski P, Hryniewiecki T, Kuśmierczyk M, et al. The usefulness of se‑
lected biomarkers in aortic regurgitation. Cardiol J. 2018. [epub ahead of print].
12  Simonneau G, Galiè N, Rubin lJ, et al. Clinical classification of pulmonary hy‑
pertension. J Am Coll Cardiol. 2004; 43 (suppl): S5‑S12.
13  Delgado JF, Conde e, Sánchez V, et al. Pulmonary vascular remodeling in pul‑
monary hypertension due to chronic heart failure. eur J Heart Fail. 2005; 7: 1011‑1016.
14  Duchnowski P, Hryniewiecki T, Kuśmierczyk M, Szymański P. The usefulness of se‑
lected biomarkers in patients with valve disease. biomark Med. 2018; 12: 1341‑1346.
15  Świątkiewicz I, Taub PR. The usefulness of C ‑reactive protein for the predic‑
tion of post ‑infarct left ventricular systolic dysfunction and heart failure. Kardiol 
Pol. 2018; 76: 821‑829.
